跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,585 条关于
“Paroxysmal Nocturnal Haemoglobinuria”
全部
1,585
临床试验
1,356
药物
12
机构
1
资讯
216
2年前
Roche's PiaSky Approved in EU as First Monthly Self-Administered Treatment for Paroxysmal Nocturnal Haemoglobinuria
去年
AstraZeneca's Oral Drug Danicopan Receives CHMP Backing for PNH-Related Anaemia Treatment
去年
FDA Blocks Approval of AstraZeneca's Ultomiris for Neuromyelitis Optica Spectrum Disorder
去年
FDA Initiates Review of Roche's Monthly Injectable Crovalimab for Rare Blood Disorder PNH
去年
Alexion Launches Phase 3 Trial of Ultomiris for Severe COVID-19 Pneumonia
去年
Novartis' Fabhalta Demonstrates Sustained Benefits in Phase III Trial for C3 Glomerulopathy
去年
Fabhalta Demonstrates Sustained Efficacy in Phase 3 Trial for C3 Glomerulopathy
去年
EMA Panel Recommends Sparsentan for IgA Nephropathy, Paving Way for EU Approval
去年
Roche's PiaSky Becomes First Subcutaneous PNH Therapy Approved in EU
2年前
Hong Kong Approves Two New Drugs for Hypercalcemia Under "1+" Mechanism
第 1 页，共 22 页
上一页
下一页
